Nyxoah SA Form 6-K Summary
Business Context and Reporting Period
This Form 6-K was filed by Nyxoah SA on July 5, 2024, covering the month of July 2024. The filing announces a significant financing event: a loan facility agreement with the European Investment Bank (EIB) backed by the European Commission's InvestEU program.
Key Financial Metrics
The filing does not provide revenue, profit, cash flow, or margin data. The primary financial metric disclosed is the new debt facility:
- Total Loan Facility: €37.5 million
- Tranche A (Initial): €10.0 million
- Tranche B: €13.75 million
- Tranche C: €13.75 million
- Interest Rate (Tranche A): 5% cash interest and 5% capitalized interest annually
- Repayment Structure: Five-year bullet repayment schedule
- Covenants: No revenue or liquidity covenants
Material Changes
The material change reported is the execution of the Loan Agreement on July 3, 2024. This represents a new source of long-term capital intended for research and development and scaling manufacturing capacity in Europe and the U.S. Additionally, the Company entered into a "synthetic warrant agreement" with the EIB as a condition for the drawdown.
Outlook, Risks, and Unusual Items
Use of Proceeds: Funding is designated for R&D and manufacturing scale-up to meet demand.
Synthetic Warrants: In connection with Tranche A, the EIB will receive 468,384 synthetic warrants with a strike price of €8.11. These warrants have a 20-year duration and can be exercised after the maturity of the relevant tranche (5 years) or in exceptional situations. Upon exercise, the EIB receives cash consideration based on the 20-day volume-weighted average share price minus the strike price.
Conditions: Disbursement of tranches is subject to certain conditions specified in the agreement.
Investor Verification Checklist
- Verify the specific conditions precedent required for the disbursement of Tranches B and C.
- Review the full terms of the synthetic warrant agreement to understand potential dilution or cash outflow scenarios upon exercise.
- Confirm the impact of the 5% capitalized interest on future interest expense and cash flow requirements.
- Assess the Company's current cash position relative to the €10.0 million initial tranche drawdown.